HERCULES, Calif. — June 6, 2017 — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today announced the launch of an RT-PCR kit that allows researchers to simultaneously screen samples for Zika (ZIKV), dengue (DENV1, DENV2, DENV3, DENV4), and chikungunya (CHIKV) arbovirus RNAs. The assay comes with all the controls researchers need to internally validate the results. This assay is approved for Research Use Only and is currently available only outside the U.S.
The ZDC Multiplex RT-PCR Assay (Research Use Only) is a one-step reverse-transcription, real-time PCR assay for the simultaneous detection and quantification of ZIKV, DENV, and CHIKV RNAs from a large range of specimen types.
“Our assay provides researchers an effective and reliable tool for the concurrent detection of Zika, dengue, and chikungunya RNAs in a single reaction tube,” said Luca Boveri, PhD, Bio-Rad Global Product Manager, Gene Expression. “Researchers can now rely on a wet-lab validated tool whose key components have been manufactured in GMP-approved facilities and extensively tested to generate consistent results.”
Independent screening for Zika, dengue, and chikungunya can be time-consuming and challenging, particularly when the number of samples is sizable or the amount of starting material is limited, as is often the case when dealing with serum, blood, or even mosquitoes. By taking advantage of a multiplex setup that includes the capability to detect all three viral targets and up to two different controls in a single tube, Bio-Rad’s assay delivers a sensitive tool that maintains excellent linearity and efficiency while also providing a streamlined workflow.
Bio-Rad has validated its assay on popular real-time PCR platforms, thus assuring investigators of consistency across different instruments. Bio-Rad rigorously evaluated and optimized the assay for specificity, sensitivity, reproducibility, and efficiency.
Other Key Benefits
One-step RT-PCR protocol for a streamlined workflow
Up to 5-plex capability, including viral targets and controls
Kit contains all components needed to run 200 reactions
For more information on the ZDC Multiplex RT-PCR Assay, please visit www.bio-rad.com/zdc
About ZDC Multiplex Kit
Bio-Rad’s ZDC Multiplex RT-PCR Assay is compatible with Bio-Rad’s CFX96™ and CFX96 Touch™ Real-Time PCR Detection Systems and other commonly used qPCR instruments. The kit includes: ZDC Multiplex Assay Mix, ZDC Positive Control, ZDC Internal Control, iTaq™ Universal Probes One-Step Reaction Mix, iScript™ Reverse Transcriptase, ZDC Buffer T, and nuclease-free water. This assay is intended for Research Use Only and is currently available only outside the U.S.
Bio-Rad’s thermal cyclers and real-time thermal cyclers are covered by one or more of the following U.S. patents or their foreign counterparts owned by Eppendorf AG: U.S. Patent Numbers 6,767,512 and 7,074,367.
About Bio-Rad
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) develops, manufactures, and markets a broad range of innovative products and solutions for the life science research and clinical diagnostic markets. The company is renowned for its commitment to quality and customer service among university and research institutions, hospitals, public health and commercial laboratories, as well as the biotechnology, pharmaceutical, and food safety industries. Founded in 1952, Bio-Rad is based in Hercules, California, and serves more than 100,000 research and healthcare industry customers through its global network of operations. The company employs more than 8,250 people worldwide and had revenues exceeding $2 billion in 2016. For more information, please visit www.bio-rad.com.
